Other Viruses Citation List: January 17, 2013 - January 30, 2014
Hepatitis A Virus
1. Anti-infective and Cytotoxic Properties of Bupleurum marginatum. Ashour, M.L., M.Z. El-Readi, R. Hamoud, S.Y. Eid, S.H. El Ahmady, E. Nibret, F. Herrmann, M. Youns, A. Tahrani, D. Kaufmann, and M. Wink. Chinese Medicine, 2014. 9(1): p. 4; PMID[24438177].
[PubMed]. OV_0117-013014.
Hepatitis B Virus
2. A New Inositol Triester from Taraxacum mongolicum. Liu, J., N. Zhang, and M. Liu. Natural Product Research, 2014. [Epub ahead of print]. PMID[24432736].
[PubMed]. OV_0117-013014.
3. Evaluation and Identification of Hepatitis B Virus Entry Inhibitors Using HepG2 Cells Overexpressing a Membrane Transporter NTCP. Iwamoto, M., K. Watashi, S. Tsukuda, H.H. Aly, M. Fukasawa, A. Fujimoto, R. Suzuki, H. Aizaki, T. Ito, O. Koiwai, H. Kusuhara, and T. Wakita. Biochemical and Biophysical Research Communications, 2014. 443(3): p. 808-813; PMID[24342612].
[PubMed]. OV_0117-013014.
Hepatitis C Virus
4. Integrated Strategies for Identifying Leads That Target the NS3 Helicase of the Hepatitis C Virus. Laplante, S.R., A.K. Padyana, A. Abeywardane, P. Bonneau, M. Cartier, R. Coulombe, A. Jakalian, J. Wildeson-Jones, X. Li, S. Liang, G. McKercher, P. White, Q. Zhang, and S.J. Taylor. Journal of Medicinal Chemistry, 2014. [Epub ahead of print]. PMID[24467709].
[PubMed]. OV_0117-013014.
5. Analysis of the Hepatitis C Viral Kinetics during Administration of Two Nucleotide Analogues: Sofosbuvir (GS-7977) and GS-0938. Guedj, J., P.S. Pang, J. Denning, M. Rodriguez-Torres, E. Lawitz, W. Symonds, and A.S. Perelson. Antiviral Therapy, 2014. [Epub ahead of print]. PMID[24464551].
[PubMed]. OV_0117-013014.
6. Multiple e-Pharmacophore Modeling, 3D-QSAR and High-throughput Virtual Screening of Hepatitis C Virus NS5B Polymerase Inhibitors. Kaushik-Basu, N., P.J. Theresa, D. Manvar, S. Kondepudi, M.B. Battu, D. Sriram, A. Basu, and P. Yogeeswari. Journal of Chemical Information and Modeling, 2014. [Epub ahead of print]. PMID[24460140].
[PubMed]. OV_0117-013014.
7. Identification and Biochemical Characterization of Halisulfate 3 and Suvanine as Novel Inhibitors of Hepatitis C Virus NS3 Helicase from a Marine Sponge. Furuta, A., K.A. Salam, I. Hermawan, N. Akimitsu, J. Tanaka, H. Tani, A. Yamashita, K. Moriishi, M. Nakakoshi, M. Tsubuki, P.W. Peng, Y. Suzuki, N. Yamamoto, Y. Sekiguchi, S. Tsuneda, and N. Noda. Marine Drugs, 2014. 12(1): p. 462-476; PMID[24451189].
[PubMed]. OV_0117-013014.
8. Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor. Rosenquist, A., B. Samuelsson, P.O. Johansson, M.D. Cummings, O. Lenz, P. Raboisson, K. Simmen, S. Vendeville, H. de Kock, M. Nilsson, A. Horvath, R. Kalmeijer, G. de la Rosa, and M. Beaumont-Mauviel. Journal of Medicinal Chemistry, 2014. [Epub ahead of print]. PMID[24446688].
[PubMed]. OV_0117-013014.
9. Antiviral Activity of Extracts from Morinda citrifolia Leaves and Chlorophyll Catabolites, Pheophorbide A and Pyropheophorbide A, against Hepatitis C Virus. Ratnoglik, S.L., C. Aoki, P. Sudarmono, M. Komoto, L. Deng, I. Shoji, H. Fuchino, N. Kawahara, and H. Hotta. Microbiology and Immunology, 2014. [Epub ahead of print]. PMID[24438164].
[PubMed]. OV_0117-013014.
10. Hepatitis C Virus NS5A Replication Complex Inhibitors. Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotype with Inhibitory Activity toward Genotypes 1a and 1b Replicons. Belema, M., V.N. Nguyen, J.L. Romine, D.R. St Laurent, O.D. Lopez, J.T. Goodrich, P.T. Nower, D.R. O'Boyle, 2nd, J.A. Lemm, R.A. Fridell, M. Gao, H. Fang, R.G. Krause, Y.K. Wang, A.J. Oliver, A.C. Good, J.O. Knipe, N.A. Meanwell, and L.B. Snyder. Journal of Medicinal Chemistry, 2014. [Epub ahead of print]. PMID[24437689].
[PubMed]. OV_0117-013014.
11. Synthesis, Cytostatic, Antimicrobial, and anti-HCV Activity of 6-Substituted 7-(Het)aryl-7-deazapurine ribonucleosides. Naus, P., O. Caletkova, P. Konecny, P. Dzubak, K. Bogdanova, M. Kolar, J. Vrbkova, L. Slavetinska, E. Tloust'ova, P. Perlikova, M. Hajduch, and M. Hocek. Journal of Medicinal Chemistry, 2014. [Epub ahead of print]. PMID[24397620].
[PubMed]. OV_0117-013014.
Epstein-Barr Virus
12. Inhibition of Epstein-Barr Virus Lytic Cycle by an Ethyl acetate Subfraction Separated from Polygonum cuspidatum Root and Its Major Component, Emodin. Yiu, C.Y., S.Y. Chen, T.H. Yang, C.J. Chang, D.B. Yeh, Y.J. Chen, and T.P. Lin. Molecules, 2014. 19(1): p. 1258-1272; PMID[24448066].
[PubMed]. OV_0117-013014.
Herpes Simplex Virus 1
13. Herpes Simplex Virus Type-1 Attachment Inhibition by Functionalized Graphene oxide. Sametband, M., I. Kalt, A. Gedanken, and R. Sarid. ACS Applied Materials & Interfaces, 2014. 6(2): p. 1228-1235; PMID[24364493].
[PubMed]. OV_0117-013014.
14. The System of Fucoidans from the Brown Seaweed Dictyota dichotoma: Chemical Analysis and Antiviral Activity. Rabanal, M., N.M. Ponce, D.A. Navarro, R.M. Gomez, and C.A. Stortz. Carbohydrate Polymers, 2014. 101: p. 804-811; PMID[24299842].
[PubMed]. OV_0117-013014.
Citations from the ISI Web of Knowledge Listings for O.V.
15. New Inhibitors of Cytomegalovirus DNA Polymerase. Abdel-Magid, A.F. ACS Medicinal Chemistry Letters, 2013. 4(12): p. 1129-1130; ISI[000328529400002].
[WOS]. OV_0117-013014.
16. Anti-Herpes Virus Activity of Silibinin, the Primary Active Component of Silybum marianum. Cardile, A.P. and G.K.N. Mbuy. Journal of Herbal Medicine, 2013. 3(4): p. 132-136; ISI[000328914700002].
[WOS]. OV_0117-013014.
17. Synthesis and Biological Evaluation of Biphenyl amides That Modulate the US28 Receptor. Kralj, A., E. Kurt, N. Tschammer, and M.R. Heinrich. ChemMedChem, 2014. 9(1): p. 151-168; ISI[000328747700012].
[WOS]. OV_0117-013014.
18. Identification of Novel Small Molecules as Inhibitors of Hepatitis C Virus by Structure-based Virtual Screening. Li, J., X. Liu, S.S. Li, Y.L. Wang, N.N. Zhou, C. Luo, X.M. Luo, M.Y. Zheng, H.L. Jiang, and K.X. Chen. International Journal of Molecular Sciences, 2013. 14(11): p. 22845-22856; ISI[000328624400096].
[WOS]. OV_0117-013014.
19. Artemisinin Analogues as Potent Inhibitors of in Vitro Hepatitis C Virus Replication. Obeid, S., J. Alen, V.H. Nguyen, V.C. Pham, P. Meuleman, C. Pannecouque, T.N. Le, J. Neyts, W. Dehaen, and J. Paeshuyse. Plos One, 2013. 8(12): p. e81783 ; ISI[000328730300050].
[WOS]. OV_0117-013014.
20. Chemically Engineered Sulfated Glucans from Rice Bran Exert Strong Antiviral Activity at the Stage of Viral Entry. Ray, B., C. Hutterer, S.S. Bandyopadhyay, K. Ghosh, U.R. Chatterjee, S. Ray, I. Zeittrager, S. Wagner, and M. Marschall. Journal of Natural Products, 2013. 76(12): p. 2180-2188; ISI[000329331200002].
[WOS]. OV_0117-013014.